Although SARS-CoV-2 antibody titers remained detectable for those patients throughout the felzartamab treatment phase and with the observed reduction being in line with data on antibody kinetics in healthy individuals,S15 a final conclusion within the impact of felzartamab treatment on SARS-CoV-2 antibody kinetics cannot yet be made, as direct comparison to an untreated population is not available - DHFR inhibitors in non-small cell lung cancer

Although SARS-CoV-2 antibody titers remained detectable for those patients throughout the felzartamab treatment phase and with the observed reduction being in line with data on antibody kinetics in healthy individuals,S15 a final conclusion within the impact of felzartamab treatment on SARS-CoV-2 antibody kinetics cannot yet be made, as direct comparison to an untreated population is not available

Although SARS-CoV-2 antibody titers remained detectable for those patients throughout the felzartamab treatment phase and with the observed reduction being in line with data on … Continue reading Although SARS-CoV-2 antibody titers remained detectable for those patients throughout the felzartamab treatment phase and with the observed reduction being in line with data on antibody kinetics in healthy individuals,S15 a final conclusion within the impact of felzartamab treatment on SARS-CoV-2 antibody kinetics cannot yet be made, as direct comparison to an untreated population is not available